AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycicheck M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Astorion Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glycicheck M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is vital, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are crucial for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (sugary foods or juice) are essential. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating women should seek medical advice. Regular blood glucose monitoring, along with blood cell count and liver function tests as directed by your physician, is necessary.

Uses of Glycicheck M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glycicheck M 1mg/500mg Tablet:

Consume Glycicheck M 1mg/500mg tablets precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Administration should coincide with mealtimes.

Common Side effects of Glycicheck M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glycicheck M 1mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycicheck M 1mg/500mg tablets should be administered with a meal.

How Glycicheck M 1mg/500mg Tablet works:

Glycicheck M, a 1mg/500mg tablet, unites the antidiabetic actions of glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through decreased hepatic glucose production, slowed intestinal glucose uptake, and improved insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glycicheck M 1mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glycicheck M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glycicheck M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glycicheck M 1mg/500mg tablets, potentially requiring dosage modification. Physician consultation is recommended. Glycicheck M 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glycicheck M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glycicheck M 1mg/500mg Tablet :

Should you forget to take a Glycicheck M 1mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glycicheck M 1mg/500mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glycicheck M 1mg/500mg Tablet

Maintain this medication within its original, securely sealed container. Follow the storage directions provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Glycicheck M 1mg/500mg Tablets can cause lactic acidosis, a serious medical condition resulting from excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon but potentially dangerous side effect of metformin, particularly risky for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms may involve muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glycicheck M 1mg/500mg Tablet use and seek immediate medical attention.
Glycicheck M, a 1mg/500mg tablet, combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when coupled with a healthy diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Glycicheck M 1mg/500mg tablets may cause common adverse reactions including low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal pain, diarrhea, and headache. Rare but potentially severe side effects such as lactic acidosis may occur. Prolonged use might result in vitamin B12 deficiency.
Glycicheck M 1mg/500mg Tablet use is associated with Vitamin B12 deficiency over extended periods. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency can lead to anemia, neurological complications including paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. Prophylactic annual Vitamin B12 supplementation is recommended by some experts to mitigate these risks.
Indeed, Glycicheck M 1mg/500mg Tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glycicheck M 1mg/500mg tablets and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Alcohol consumption also elevates the likelihood of lactic acidosis.
Glycicheck M 1mg/500mg Ta...
90
MRP 110
18% off